Washington University School of Medicine: Sarcoma trials

The registry lists 19 Sarcoma studies with Washington University School of Medicine as lead sponsor. 4 are open to participants now and 7 have results posted.

Phase 1 7Phase 2 8No phase 4(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Zanzalintinib Combined With Eribulin in Advanced Liposarcoma and LeiomyosarcomaRecruitingNCT06957431Phase 1
• Ovarian-Sparing Adaptive Radiotherapy in Young Adult WomenRecruitingNCT06904365
• Propranolol for the Treatment of Kaposi Sarcoma in AdultsRecruitingNCT06445166Phase 2
• Circulating Tumor DNA (ctDNA) for Early Treatment Response Assessment of Solid TumorsRecruitingNCT04354064
• Palliative Lattice Stereotactic Body Radiotherapy (SBRT) for Patients With Sarcoma, Thoracic, Abdominal, and Pelvic CancersCompletedNCT04553471Not applicableResults posted
• PROactive Evaluation of Function to Avoid CardioToxicityTerminatedNCT03862131Phase 2Results posted
• ADI-PEG 20 in Combination With Gemcitabine and Docetaxel for the Treatment of Soft Tissue Sarcoma, Osteosarcoma, Ewing's Sarcoma, and Small Cell Lung CancerCompletedNCT03449901Phase 2Results posted
• Doxorubicin With Upfront Dexrazoxane for the Treatment of Advanced or Metastatic Soft Tissue SarcomaCompletedNCT02584309Phase 2Results posted
• Pazopanib as Front-Line Therapy in Patients With Non-Resectable or Metastatic Soft Tissue Sarcomas Who Are Not Candidates for ChemotherapyCompletedNCT02300545Phase 2Results posted
• Cryoablation, Radiofrequency Ablation, or Microwave Ablation in Treating Patients With Metastatic Sarcoma Stable on ChemotherapyTerminatedNCT01986829Phase 2Results posted
• Dacarbazine for Metastatic Soft Tissue and Bone SarcomaCompletedNCT00802880Phase 2Results posted
• Zanzalintinib in Combination With Ipilimumab and Nivolumab in Patients With Metastatic Soft Tissue SarcomaSuspendedNCT06968988Phase 1
• Neoadjuvant ADI-PEG 20 + Ifosfamide + Radiotherapy in Soft Tissue SarcomaTerminatedNCT05813327Phase 1
• Cabozantinib Combined With PD-1 and CTLA-4 Inhibition in Metastatic Soft Tissue SarcomaActive, not recruitingNCT04551430Phase 2
• Rehabilitation and Quality of Life Assessment for Soft Tissue Sarcoma Treated With Radiotherapy and SurgeryTerminatedNCT03916796Not applicable
• Magnetic Resonance-guided High-Intensity Focused Ultrasound (MR-HIFU) Used for Mild HyperthermiaWithdrawnNCT03007771Phase 1
• DHEA in Synovial Sarcoma PatientsTerminatedNCT02683148Phase 1
• Evaluation of 64Cu-DOTA-U3-1287 in Subjects With Advanced Solid TumorsTerminatedNCT01479023Phase 1
• Liposomal Doxorubicin and PSC 833 in Treating Patients With AIDS-Related Kaposi's Sarcoma or Other Advanced CancersCompletedNCT00003207Phase 1